ResMed CEO Mick Farrell said Wednesday that his company has been ramping up production of ventilators for the last 90 days, trying to meet surging global demand as countries battle the COVID-19 pandemic.
Ventilators most in-demand for COVID-19 treatment push air and oxygen into and out of a person’s lungs through tubes inserted through their mouth and trachea. They can help patients survive and recover from respiratory failure caused by the virus.
To help address a shortfall amid the global emergency, ResMed is seeking production help with some of the 500 components which go into its more sophisticated ventilators. The company is fielding offers for assistance from some of the world’s largest automotive, aerospace and defense companies, including Tesla, Farrell said on CNBC’s “Mad Money”.
ResMed made tens of thousands of its high-end ventilators in 2019, and is aiming to double or triple that in the next year, and to get those ventilators to hospitals in Singapore, Italy and the…